Mechanistic Insights on the Inhibition of C5 DNA Methyltransferases by Zebularine
Christine Champion, Dominique Guianvarc'h, Catherine Sénamaud-Beaufort et al. · 2010
Read Mechanistic Insights on the Inhibition of C5 DNA Methyltransferases by Zebularine by Christine Champion, Dominique Guianvarc'h, Catherine Sénamaud-Beaufort et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0012388.txt.
Description
Christine Champion, Dominique Guianvarc'h, Catherine Sénamaud-Beaufort and colleagues studied how the drug zebularine jams DNA methylation enzymes, in a 2010 PLOS ONE paper. In mammals, methyl tags on DNA help control which genes stay on or off, and the enzymes that place them, called DNMTs, are targets of cancer drugs. Zebularine blocks these enzymes, but the exact grip was unclear.
The team worked out how zebularine traps the C5 class of these enzymes in a stuck state. Knowing the trap in detail helps chemists design stronger, more selective blockers. Better DNMT drugs could reactivate silenced tumor guard genes in cancer while limiting side effects on healthy cells.
Catalog record
| CREATOR | Christine Champion, Dominique Guianvarc'h, Catherine Sénamaud-Beaufort et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012388